Net Cash Provided by (Used in) Operating Activities |
-15.3M |
USD |
+74% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
40.7M |
USD |
+46% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
25.4M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
160M |
USD |
+2594% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
1.28M |
USD |
+1426% |
Mar 31, 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Income Tax Expense (Benefit) |
2.46M |
USD |
-23% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.16M |
USD |
+24.6% |
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
3.01M |
USD |
+38.5% |
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
27K |
USD |
-90.1% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
894M |
USD |
+32.5% |
Mar 31, 2024 |
Q1 2024 |
Current State and Local Tax Expense (Benefit) |
0 |
USD |
-100% |
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
-100% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
741K |
USD |
-12.9% |
Mar 31, 2024 |
Q1 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
205K |
USD |
+4.59% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |